Clinical Trial Update: A Mass Balance Study of [14C]-Nanatinostat and Relative Bioavailability Study of Nanatinostat in Patients With Advanced Cancers [Phase 1]

View source ↗

Summary

A Phase 1 mass balance study of [14C]-Nanatinostat and a relative bioavailability study of Nanatinostat in patients with advanced cancers have been terminated. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Nanatinostat (nanatinostat)

Snippet

Sponsor: Viracta Therapeutics, Inc. | Conditions: Advanced Cancer | Phase 1 | Status: TERMINATED